The ability of the model to mimic clinical rates of tumor ER-status so closely, particularly with regard to a mutation in a single gene (BRCA1) demonstrates the potential benefit and utility of model-aided hypothesis generation and evaluation. The gene discussed is BRCA1; the disease is neoplasm.